A citation-based method for searching scientific literature

Xianfang Tang, Lijun Cai, Yajie Meng, JunLin Xu, Changcheng Lu, Jialiang Yang. Front Immunol 2021
Times Cited: 16







List of co-cited articles
61 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases.
Jialiang Yang, Shouneng Peng, Bin Zhang, Sander Houten, Eric Schadt, Jun Zhu, Yousin Suh, Zhidong Tu. Geroscience 2020
25
50

An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge Regression.
Chuanying Liu, Dong Wei, Ju Xiang, Fuquan Ren, Li Huang, Jidong Lang, Geng Tian, Yushuang Li, Jialiang Yang. Mol Ther Nucleic Acids 2020
24
50

Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method.
Liqian Zhou, Juanjuan Wang, Guangyi Liu, Qingqing Lu, Ruyi Dong, Geng Tian, Jialiang Yang, Lihong Peng. Genomics 2020
16
37

A systematic study on drug-response associated genes using baseline gene expressions of the Cancer Cell Line Encyclopedia.
Xiaoming Liu, Jiasheng Yang, Yi Zhang, Yun Fang, Fayou Wang, Jun Wang, Xiaoqi Zheng, Jialiang Yang. Sci Rep 2016
36
31

DrugBank 5.0: a major update to the DrugBank database for 2018.
David S Wishart, Yannick D Feunang, An C Guo, Elvis J Lo, Ana Marcu, Jason R Grant, Tanvir Sajed, Daniel Johnson, Carin Li, Zinat Sayeeda,[...]. Nucleic Acids Res 2018
31

Discover the network underlying the connections between aging and age-related diseases.
Jialiang Yang, Tao Huang, Won-Min Song, Francesca Petralia, Charles V Mobbs, Bin Zhang, Yong Zhao, Eric E Schadt, Jun Zhu, Zhidong Tu. Sci Rep 2016
27
31

Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures.
Lihong Peng, Ling Shen, Junlin Xu, Xiongfei Tian, Fuxing Liu, Juanjuan Wang, Geng Tian, Jialiang Yang, Liqian Zhou. Sci Rep 2021
12
33

Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction.
Lihong Peng, Xiongfei Tian, Ling Shen, Ming Kuang, Tianbao Li, Geng Tian, Jialiang Yang, Liqian Zhou. Front Genet 2020
11
36

Molecular Network-Based Drug Prediction in Thyroid Cancer.
Xingyu Xu, Haixia Long, Baohang Xi, Binbin Ji, Zejun Li, Yunyue Dang, Caiying Jiang, Yuhua Yao, Jialiang Yang. Int J Mol Sci 2019
10
40

Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review.
Tianbao Li, Tao Huang, Cheng Guo, Ailan Wang, Xiaoli Shi, Xiaofei Mo, Qingqing Lu, Jing Sun, Tingting Hui, Geng Tian,[...]. Innovation (N Y) 2021
14
28


A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.
Aravind Subramanian, Rajiv Narayan, Steven M Corsello, David D Peck, Ted E Natoli, Xiaodong Lu, Joshua Gould, John F Davis, Andrew A Tubelli, Jacob K Asiedu,[...]. Cell 2017
978
18

Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
Haiyan Liu, Chun Qiu, Bo Wang, Pingping Bing, Geng Tian, Xueliang Zhang, Jun Ma, Bingsheng He, Jialiang Yang. Front Cell Dev Biol 2021
23
18

TOOme: A Novel Computational Framework to Infer Cancer Tissue-of-Origin by Integrating Both Gene Mutation and Expression.
Binsheng He, Jidong Lang, Bo Wang, Xiaojun Liu, Qingqing Lu, Jianjun He, Wei Gao, Pingping Bing, Geng Tian, Jialiang Yang. Front Bioeng Biotechnol 2020
21
18

A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
Bingsheng He, Chan Dai, Jidong Lang, Pingping Bing, Geng Tian, Bo Wang, Jialiang Yang. Biochim Biophys Acta Mol Basis Dis 2020
11
27

Drug repositioning based on the heterogeneous information fusion graph convolutional network.
Lijun Cai, Changcheng Lu, Junlin Xu, Yajie Meng, Peng Wang, Xiangzheng Fu, Xiangxiang Zeng, Yansen Su. Brief Bioinform 2021
9
33

Predicting drug-disease associations through layer attention graph convolutional network.
Zhouxin Yu, Feng Huang, Xiaohan Zhao, Wenjie Xiao, Wen Zhang. Brief Bioinform 2021
33
18

Solving the apparent diversity-accuracy dilemma of recommender systems.
Tao Zhou, Zoltán Kuscsik, Jian-Guo Liu, Matús Medo, Joseph Rushton Wakeling, Yi-Cheng Zhang. Proc Natl Acad Sci U S A 2010
81
12

Prediction of drug-target interactions and drug repositioning via network-based inference.
Feixiong Cheng, Chuang Liu, Jing Jiang, Weiqiang Lu, Weihua Li, Guixia Liu, Weixing Zhou, Jin Huang, Yun Tang. PLoS Comput Biol 2012
417
12

Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy.
Hanchuan Peng, Fuhui Long, Chris Ding. IEEE Trans Pattern Anal Mach Intell 2005
12

Network-based in silico drug efficacy screening.
Emre Guney, Jörg Menche, Marc Vidal, Albert-László Barábasi. Nat Commun 2016
203
12

Neighborhood Regularized Logistic Matrix Factorization for Drug-Target Interaction Prediction.
Yong Liu, Min Wu, Chunyan Miao, Peilin Zhao, Xiao-Li Li. PLoS Comput Biol 2016
133
12



DrugComboRanker: drug combination discovery based on target network analysis.
Lei Huang, Fuhai Li, Jianting Sheng, Xiaofeng Xia, Jinwen Ma, Ming Zhan, Stephen T C Wong. Bioinformatics 2014
88
12


Data-driven prediction of drug effects and interactions.
Nicholas P Tatonetti, Patrick P Ye, Roxana Daneshjou, Russ B Altman. Sci Transl Med 2012
335
12

The SIDER database of drugs and side effects.
Michael Kuhn, Ivica Letunic, Lars Juhl Jensen, Peer Bork. Nucleic Acids Res 2016
380
12

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases.
Ahmet Sureyya Rifaioglu, Heval Atas, Maria Jesus Martin, Rengul Cetin-Atalay, Volkan Atalay, Tunca Doğan. Brief Bioinform 2019
114
12

Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd.
Zichen Wang, Caroline D Monteiro, Kathleen M Jagodnik, Nicolas F Fernandez, Gregory W Gundersen, Andrew D Rouillard, Sherry L Jenkins, Axel S Feldmann, Kevin S Hu, Michael G McDermott,[...]. Nat Commun 2016
127
12

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.
Michael I Love, Wolfgang Huber, Simon Anders. Genome Biol 2014
12

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.
Katarzyna Tomczak, Patrycja Czerwińska, Maciej Wiznerowicz. Contemp Oncol (Pozn) 2015
12

WGCNA: an R package for weighted correlation network analysis.
Peter Langfelder, Steve Horvath. BMC Bioinformatics 2008
12

Matrix completion with side information and its applications in predicting the antigenicity of influenza viruses.
Li Huang, Xianhong Li, Pengfei Guo, Yuhua Yao, Bo Liao, Weiwei Zhang, Fayou Wang, Jiasheng Yang, Yulong Zhao, Hailiang Sun,[...]. Bioinformatics 2017
11
18

Revealing Drug-Target Interactions with Computational Models and Algorithms.
Liqian Zhou, Zejun Li, Jialiang Yang, Geng Tian, Fuxing Liu, Hong Wen, Li Peng, Min Chen, Ju Xiang, Lihong Peng. Molecules 2019
20
12

Using sequence data to infer the antigenicity of influenza virus.
Hailiang Sun, Jialiang Yang, Tong Zhang, Li-Ping Long, Kun Jia, Guohua Yang, Richard J Webby, Xiu-Feng Wan. mBio 2013
61
12

A Novel Coronavirus from Patients with Pneumonia in China, 2019.
Na Zhu, Dingyu Zhang, Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao, Baoying Huang, Weifeng Shi, Roujian Lu,[...]. N Engl J Med 2020
12

Predicting the frequencies of drug side effects.
Diego Galeano, Shantao Li, Mark Gerstein, Alberto Paccanaro. Nat Commun 2020
15
13


Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Jonathan Grein, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L Green, François-Xavier Lescure,[...]. N Engl J Med 2020
12

Drug repurposing: progress, challenges and recommendations.
Sudeep Pushpakom, Francesco Iorio, Patrick A Eyers, K Jane Escott, Shirley Hopper, Andrew Wells, Andrew Doig, Tim Guilliams, Joanna Latimer, Christine McNamee,[...]. Nat Rev Drug Discov 2019
12

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.
Justin Lamb, Emily D Crawford, David Peck, Joshua W Modell, Irene C Blat, Matthew J Wrobel, Jim Lerner, Jean-Philippe Brunet, Aravind Subramanian, Kenneth N Ross,[...]. Science 2006
12

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
12

Discovery and development of safe-in-man broad-spectrum antiviral agents.
Petter I Andersen, Aleksandr Ianevski, Hilde Lysvand, Astra Vitkauskiene, Valentyn Oksenych, Magnar Bjørås, Kaidi Telling, Irja Lutsar, Uga Dumpis, Yasuhiko Irie,[...]. Int J Infect Dis 2020
84
12

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.
Sepideh Sadegh, Julian Matschinske, David B Blumenthal, Gihanna Galindez, Tim Kacprowski, Markus List, Reza Nasirigerdeh, Mhaned Oubounyt, Andreas Pichlmair, Tim Daniel Rose,[...]. Nat Commun 2020
84
12

A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.
C R Lindsay, V Faugeroux, S Michiels, E Pailler, F Facchinetti, D Ou, M V Bluthgen, C Pannet, M Ngo-Camus, G Bescher,[...]. Ann Oncol 2017
55
12

PREDICT: a method for inferring novel drug indications with application to personalized medicine.
Assaf Gottlieb, Gideon Y Stein, Eytan Ruppin, Roded Sharan. Mol Syst Biol 2011
364
12

Remdesivir against COVID-19 and Other Viral Diseases.
Jakob J Malin, Isabelle Suárez, Vanessa Priesner, Gerd Fätkenheuer, Jan Rybniker. Clin Microbiol Rev 2020
77
12


AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.
Garrett M Morris, Ruth Huey, William Lindstrom, Michel F Sanner, Richard K Belew, David S Goodsell, Arthur J Olson. J Comput Chem 2009
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.